LivingGLP1
Study S001049

Liraglutide Effectiveness in Preoperative Weight-loss for Patients With Severe Obesity Undergoing Bariatric-metabolic Surgery.

Registration

Registration
NCT06201819
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
COMPLETED
Enrollment
37
Start
2022-12-18
Primary completion
2023-03-18
Lead sponsor
Hospital Civil Juan I. Menchaca
Conditions
Weight Loss; Bariatric Surgery Candidate; Obesity, Morbid
Interventions
DRUG:Liraglutide injection
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Preoperative weight changes [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.